Today’s Top Movers:
$MEDS $TPST $DLXY $RETO $FTFT $MEDS - DataMeds shares are trading higher after the company announced it acquired Helomics. $DLXY...
Liliana is a seasoned financial journalist with enthusiasm for unraveling the complexities of market fluctuations and identifying paradigm-shifting trends within the stock market landscape. With years of experience in covering the stock market and publicly traded companies, Liliana has honed her skills in turning press releases into concise, informative articles. For tips and inquiries, reach out to Liliana at tips@stoxpo.com.
$MEDS $TPST $DLXY $RETO $FTFT $MEDS - DataMeds shares are trading higher after the company announced it acquired Helomics. $DLXY...
Potential partnership could bring SK Hynix memory production to U.S. soil for the first time as AI demand fuels a...
Record quarterly revenue, expanding government contracts and a $865 million cash position strengthen Planet’s push into AI-powered geospatial intelligence and...
Revenue fell 4% to $2.4 billion and comparable sales dropped 9%, while management outlined plans to strengthen products and marketing...
Revenue climbed 35% while product revenue grew 37%, prompting Snowflake to raise its full-year growth and operating margin forecasts. Snowflake...
The investment bank sets a $92 price target as AST SpaceMobile approaches commercial operations with more than 60 mobile carrier...
Sono Group, GoPro, bioAffinity, and AEye Sono Group (SONO) shares are trading higher after the company announced it entered into...
Revenue jumps 38% while subscription ARR reaches $1.66 billion and management forecasts stronger growth and cash generation Rubrik (RBRK) delivered...
Cybersecurity leader posts record net new ARR, raises full-year outlook and sees growing AI adoption creating a major security opportunity...
Data center sales surge 117% as Nvidia forecasts $108 billion in third-quarter revenue and signals AI infrastructure spending remains strong...
© 2024 All Rights Reserved: STOXPO.
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More
In case of sale of your personal information, you may opt out by using the link Do Not Sell My Personal Information
Do you really wish to opt-out?